MYH11 Antibodies

Santa Cruz Biotechnology delivers a wide array of MYH11 monoclonal antibodies for research focused on understanding MYH11 in various biological processes. MYH11 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYH11, or myosin heavy chain 11, functions as a crucial component of smooth muscle cells and plays a significant role in muscle contraction and cellular motility. MYH11 actively participates in various physiological processes, including vascular development and maintenance of blood vessel integrity. Dysregulation of MYH11 has been implicated in several cardiovascular diseases, making it an important target for research. Researchers can utilize MYH11 monoclonal antibodies to explore cellular pathways and mechanisms involved in smooth muscle function. Advanced research techniques supported by MYH11 monoclonal antibodies enable detailed investigation of vascular development and disease progression. Understanding MYH11's role in cardiovascular health opens new possibilities for therapeutic interventions. Santa Cruz Biotechnology's MYH11 monoclonal antibodies support the scientific community in advancing cardiovascular research and developing potential treatments for related diseases.